Marginal zone B-cells, a gatekeeper of innate immunity

Frontiers in Immunology

Volumn 2, Issue DEC, 2011, Pages

  Zouali, Moncef ^a,b   Richard, Yolande ^b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT COCHIN   (France)

Author keywords

Cynomolgus macaque; Hiv 1; Peptostreptococcus magnus; Protein A; Simian immunodeficiency virus; Staphylococcus aureus; Superantigen

Indexed keywords

EID: 84871390215     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00063     Document Type: Article

References (71)

1. Aichele, P., Zinke, J., Grode, L., Schwen-dener, R. A., Kaufmann, S. H., and Seiler, P. (2003). Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dis-pensable for induction of specific T cell responses. J. Immunol. 171, 1148-1155.
2. Archer, G. L. (1998). Staphylococcus aureus: a well-armed pathogen. Clin. Infect. Dis. 26, 1179-1181.
3. Attanavanich, K., and Kearney, J. F. (2004). Marginal zone, but not fol-licular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172, 803-811.
4. Badr, G., Borhis, G., Lefevre, E. A., Chaoul, N., Deshayes, F., Dessirier, V., Lapree, G., Tsapis, A., and Richard, Y. (2008). BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 111, 2744-2754.
5. Badr, G., Borhis, G., Treton, D., Moog, C., Garraud, O., and Richard, Y. (2005). HIV type 1 glycoprotein 120 inhibits human B cell chemotaxis to CXC chemokine ligand (CXCL) 12, CC chemokine ligand (CCL)20, and CCL21. J. Immunol. 175, 302-310.
6. Belperron, A. A., Dailey, C. M., and Bockenstedt, L. K. (2005). Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J. Immunol. 174, 5681-5686.
7. Belperron, A. A., Dailey, C. M., Booth, C. J., and Bockenstedt, L. K. (2007). Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection. Infect. Immun. 75, 3354-3360.
8. Bendelac, A., Savage, P. B., and Teyton, L. (2007). The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336.
9. Berberian, L., Goodglick, L., Kipps, T. J., and Braun, J. (1993). Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261, 1588-1591.
10. Bialecki, E., Paget, C., Fontaine, J., Capron, M., Trottein, F., and Faveeuw, C. (2009). Role of marginal zone B lymphocytes in invariant NKT cell activation. J. Immunol. 182, 6105-6113.
11. Birjandi, S. Z., Ippolito, J. A., Ramado-rai, A. K., and Witte, P. L. (2011). Alterations in marginal zone macrophages and marginal zone B cells in old mice. J. Immunol. 186, 3441-3451.
12. Cagigi, A., Nilsson, A., De Mil-ito, A., and Chiodi, F. (2008). B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design. Vaccine 26, 3016-3025.
13. Carsetti, R., Rosado, M. M., and Wardmann, H. (2004). Peripheral development of B cells in mouse and man. Immunol. Rev. 197, 179-191.
14. Chen, Y., Pikkarainen, T., Elomaa, O., Soininen, R., Kodama, T., Kraal, G., and Tryggvason,K. (2005). Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 anti-gen in mice lacking scavenger receptors MARCO and SR-A. J. Immunol. 175, 8173-8180.
15. Chong, Y., Ikematsu, H., Kikuchi, K., Yamamoto, M., Murata, M., Nishimura, M., Nabeshima, S., Kashiwagi, S., and Hayashi, J. (2004). Selective CD27+ (memory) B cell reduction and characteristic B cell alteration in drug-naive and HAART-treated HIV type 1-infected patients. AIDS Res. Hum. Retroviruses 20, 219-226.
16. Dammers, P. M., Visser, A., Popa, E. R., Nieuwenhuis, P., and Kroese, F. G. (2000). Most marginal zone B cells in rat express germline encoded Ig VH genes and are ligand selected. J. Immunol. 165, 6156-6169.
17. De Milito, A., Morch, C., Sonner-borg, A., and Chiodi, F. (2001). Loss of memory (CD27) B lympho-cytes in HIV-1 infection. AIDS 15, 957-964.
18. Di Sabatino, A., Rosado, M. M., Miele, L., Capolunghi, F., Cazzola, P., Biancheri, P., Carsetti, R., Gasbar-rini, G., and Corazza, G. R. (2007). Impairment of splenic IgM-memory but not switched-memory B cells in a patient with celiac disease and splenic atrophy. J. Allergy Clin. Immunol. 120, 1461-1463.
19. Dono, M., Zupo, S., Leanza, N., Meli-oli, G., Fogli, M., Melagrana, A., Chiorazzi, N., and Ferrarini, M. (2000). Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J. Immunol. 164, 5596-5604.
20. Dunn-Walters, D. K., Isaacson, P. G., and Spencer, J. (1995). Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 182, 559-566.
21. Ettinger, R., Sims, G. P., Robbins, R., Withers, D., Fischer, R. T., Grammer, A. C., Kuchen, S., and Lipsky, P. E. (2007). IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 178, 2872-2882.
22. Fontaine, J., Chagnon-Choquet, J., Val-cke, H. S., Poudrier, J., and Roger, M. (2011). High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B cell disease progression in humans. Blood 117, 145-155.
23. Hart, M., Steel, A., Clark, S. A., Moyle, G., Nelson, M., Henderson, D. C., Wilson, R., Gotch, F., Gazzard, B., and Kelleher, P. (2007). Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J. Immunol. 178, 8212-8220.
24. Hasler, P., and Zouali, M. (2003). Sub-version of B lymphocyte signaling by infectious agents. Genes Immun. 4, 95-103.
25. He, B., Qiao, X., Klasse, P. J., Chiu, A., Chadburn, A., Knowles, D. M., Moore, J. P., and Cerutti, A. (2006). HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 176, 3931-3941.
26. Herbeuval, J. P., Nilsson, J., Boasso, A., Hardy, A. W., Kruhlak, M. J., Anderson, S. A., Dolan, M. J., Dy, M., Andersson, J., and Shearer, G. M. (2006). Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl. Acad. Sci. U.S.A. 103, 7000-7005.
27. Ho, J., Moir, S., Malaspina, A., How-ell, M. L., Wang, W., Dipoto, A. C., O'Shea, M. A., Roby, G. A., Kwan, R., Mican, J. M., Chun, T. W., and Fauci, A. S. (2006). Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms. Proc. Natl. Acad. Sci. U.S.A. 103, 19436-19441.
28. Karlsson, M. C., Guinamard, R., Bol-land, S., Sankala, M., Steinman, R. M., and Ravetch, J. V. (2003). Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198, 333-340.
29. Karray, S., and Zouali, M. (1997). Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. U.S.A. 94, 1356-1360.
30. Kearney, J. F. (2008). B cell subpopulations and secondary lymphoid organ architecture. Semin. Immunol. 20, 1-3.
31. Koike, R., Nishimura, T., Yasumizu, R., Tanaka, H., Hataba, Y., Hataba, Y., Watanabe, T., Miyawaki, S., and Miyasaka, M. (1996). The splenic marginal zone is absent in alym-phoplastic aly mutant mice. Eur. J. Immunol. 26, 669-675.
32. Lanoue, A., Clatworthy, M. R., Smith, P., Green, S., Townsend, M. J., Jolin, H. E., Smith, K. G., Fallon, P. G., and Mckenzie, A. N. (2004). SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J. Exp. Med. 200, 1383-1393.
33. Legendre, C., Raphael, M., Gras, G., Lefevre, E. A., Feuillard, J., Dormont, D., and Richard, Y. (1998). CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients. Int. Immunol. 10, 1847-1851.
34. Lesley, R., Xu, Y., Kalled, S. L., Hess, D. M., Schwab, S. R., Shu, H. B., and Cyster, J. G. (2004). Reduced com-petitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20, 441-453.
35. Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., and Cerutti, A. (2002). DCs induce CD40-independent immunoglobu-lin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829.
36. Martin, F., and Kearney, J. F. (2002). Marginal-zone B cells. Nat. Rev. Immunol. 2, 323-335.
37. Odermatt, B., Eppler, M., Leist, T. P., Hengartner, H., and Zinkernagel, R. M. (1991). Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl. Acad. Sci. U.S.A. 88, 8252-8256.
38. Pack, M., Trumpfheller, C., Thomas, D., Park, C. G., Granelli-Piperno, A., Munz, C., and Steinman, R. M. (2008). DEC-205/CD205+ den-dritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp. Immunology 123, 438-446.
39. Pasare, C., and Medzhitov, R. (2005). Control of B-cell responses by Toll-like receptors. Nature 438, 364-368.
40. Peruchon, S., Chaoul, N., Burelout, C., Delache, B., Brochard, P., Lau-rent, P., Cognasse, F., Prevot, S., Garraud, O., Le Grand, R., and Richard, Y. (2009). Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection. PLoS ONE 4, e5966. doi:10.1371/journal.pone.0005966.
41. Rubtsov, A. V., Swanson, C. L., Troy, S., Strauch, P., Pelanda, R., and Tor-res, R. M. (2008). TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J. Immunol. 180, 3882-3888.
42. Samuelsson, A., Sonnerborg, A., Heuts, N., Coster, J., and Chiodi, F. (1997). Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 13, 1031-1038.
43. Scamurra, R. W., Miller, D. J., Dahl, L., Abrahamsen, M., Kapur, V., Wahl, S. M., Milner, E. C., and Janoff, E. N. (2000). Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells. J. Immunol. 164, 5482-5491.
44. Spencer, J., Perry, M. E., and Dunn-Walters, D. K. (1998). Human marginal-zone B cells. Immunol. Today 19, 421-426.
45. Steiniger, B., Timphus, E. M., and Barth, P. J. (2006). The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants. Histochem. Cell Biol. 126, 641-648.
46. Tangye, S. G., Liu, Y. J., Aversa, G., Phillips, J. H., and De Vries, J. E. (1998). Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188, 1691-1703.
47. Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., and Brink, R. (2004). Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20, 785-798.
48. Tierens,A., Delabie, J., Michiels, L.,Van-denberghe, P., and De Wolf-Peeters, C. (1999). Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 93, 226-234.
49. Timens, W. (1991). The human spleen and the immune system: not just another lymphoid organ. Res. Immunol. 142, 316-320.
50. Timens, W., Boes, A., Rozeboom-Uiterwijk, T., and Poppema, S. (1989). Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J. Immunol. 143, 3200-3206.
51. Titanji, K., Chiodi, F., Bellocco, R., Schepis, D., Osorio, L., Tassandin, C., Tambussi, G., Grutzmeier, S., Lopalco, L., and De Milito, A. (2005). Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS 19, 1947-1955.
52. Titanji, K., De Milito, A., Cagigi, A., Thorstensson, R., Grutzmeier, S., Atlas, A., Hejdeman, B., Kroon, F. P., Lopalco, L., Nilsson, A., and Chiodi, F. (2006). Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108, 1580-1587.
53. Viau, M., Cholley, B., Bjorck, L., and Zouali, M. (2004a). Down-modulation of the antigen receptor by a superantigen for human B cells. Immunol. Lett. 92, 91-96.
54. Viau, M., Longo, N. S., Lipsky, P. E., Bjorck, L., and Zouali, M. (2004b). Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L. Infect. Immun. 72, 3515-3523.
55. Viau, M., Longo, N. S., Lipsky, P. E., and Zouali, M. (2005). Staphy-lococcal protein a deletes B-1a and marginal zone B lymphocytes expressing human immunoglobulins: an immune evasion mechanism. J. Immunol. 175, 7719-7727.
56. Viau, M., Veas, F., and Zouali, M. (2007). Direct impact of inactivated HIV-1 virions on B lymphocyte subsets. Mol. Immunol. 44, 2134-2144.
57. Viau, M., and Zouali, M. (2001). Molecular determinants of the human antibody response to HIV-1: implications for disease control. J. Clin. Immunol. 21, 410-419.
58. Viau, M., and Zouali, M. (2005). B-lymphocytes, innate immunity, and autoimmunity. Clin. Immunol. 114, 17-26.
59. Weill, J., Weller, S., and Reynaud, C. (2009). Human marginal zone B cells. Annu. Rev. Immunol. 27, 267-285.
60. Weller, S., Braun, M. C., Tan, B. K., Rosenwald, A., Cordier, C., Conley, M. E., Plebani, A., Kumararatne, D. S., Bonnet, D., Tournilhac, O., Tch-ernia, G., Steiniger, B., Staudt, L. M., Casanova, J. L., Reynaud, C. A., and Weill, J. C. (2004). Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104, 3647-3654.
61. Weller, S., Mamani-Matsuda, M., Picard, C., Cordier, C., Lecoeuche, D., Gauthier, F., Weill, J. C., and Reynaud, C. A. (2008). Somatic diversification in the absence of antigen-driven responses is the hall-mark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J. Exp. Med. 205, 1331-1342.
62. Whitlock, C. A., and Watson, J. D. (1979). B-cell differentiation in the CBA/N mouse. I. Slower maturation of mitogen and antigen-responsive B cells in mice expressing an X-linked defect. J. Exp. Med. 150, 1483-1497.
63. Wilkins, B. S., Davis, Z., Lucas, S. B., Delsol, G., and Jones, D. B. (2003). Splenic marginal zone atrophy and progressive CD8+ T-cell lympho-cytosis in HIV infection: a study of adult post-mortem spleens from Cote d'Ivoire. Histopathology 42, 173-185.
64. Won, W. J., and Kearney, J. F. (2002). CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168, 5605-5611.
65. Wong, W. Y., Powars, D. R., Chan, L., Hiti, A., Johnson, C., and Overturf, G. (1992). Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience. Am. J. Hematol. 39, 176-182.
66. You, Y., Myers, R. C., Freeberg, L., Foote, J., Kearney, J. F., Juste-ment, L. B., and Carter, R. H. (2011). Marginal zone B cells regulate antigen capture by marginal zone macrophages. J. Immunol. 186, 2172-2181.
67. Zouali, M. (1995). B-cell superantigens: implications for selection of the human antibody repertoire. Immunol. Today 16, 399-405.
68. Zouali, M. (2007a). B cell superantigens subvert innate functions of B cells. Chem. Immunol. Allergy 93, 92-105.
69. Zouali, M. (2007b). Exploitation of host signaling pathways by B cell superantigens potential strategies for developing targeted therapies in systemic autoimmunity. Ann. N. Y. Acad. Sci. 1095, 342-354.
70. Zouali, M. (2008). B lymphocytes chief players and therapeutic targets in autoimmune diseases. Front. Biosci. 13, 4852-4861.
71. Zouali, M. (2009). Natural antibodies. Encyclopedia of Life Sciences. Available at: http://www.els.net(accessed September 2009).